United States
Germany
Japan
United Kingdom
China
MAP2K1 mouse monoclonal antibody,clone OTI4E1
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Primary Antibodies
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3H3 (formerly 3H3)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,990.00
2周
CNY 3,990.00
2周
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7E2 (formerly 7E2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2B2 (formerly 2B2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI8A6 (formerly 8A6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3E6 (formerly 3E6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4F1 (formerly 4F1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Mouse |
活动过滤器
优化搜索结果
Category
Reactivities
Applications
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Pathways
- Acute myeloid leukemia (235)
- B cell receptor signaling pathway (235)
- Bladder cancer (235)
- Chemokine signaling pathway (235)
- Chronic myeloid leukemia (235)
- Colorectal cancer (235)
- Dorso-ventral axis formation (235)
- Endometrial cancer (235)
- ErbB signaling pathway (235)
- Fc epsilon RI signaling pathway (235)
- Fc gamma R-mediated phagocytosis (235)
- Focal adhesion (235)
- Gap junction (235)
- Glioma (235)
- GnRH signaling pathway (235)
- Insulin signaling pathway (235)
- Long-term depression (235)
- Long-term potentiation (235)
- MAPK signaling pathway (235)
- Melanogenesis (235)
- Melanoma (235)
- Natural killer cell mediated cytotoxicity (235)
- Neurotrophin signaling pathway (235)
- Non-small cell lung cancer (235)
- Oocyte meiosis (235)
- Pancreatic cancer (235)
- Pathways in cancer (235)
- Prion diseases (235)
- Progesterone-mediated oocyte maturation (235)
- Prostate cancer (235)
- Regulation of actin cytoskeleton (235)
- Renal cell carcinoma (235)
- T cell receptor signaling pathway (235)
- Thyroid cancer (235)
- Toll-like receptor signaling pathway (235)
- VEGF signaling pathway (235)
- Vascular smooth muscle contraction (235)
